Skip to content

Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device

Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06719518
Enrollment
40
Registered
2024-12-05
Start date
2025-12-17
Completion date
2026-07-31
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure

Keywords

ViTrack, blood pressure monitoring

Brief summary

The purpose of this study is to calibrate the ViTrack™ arterial pressure waveform against intra-arterial pressure (IAP) in dynamic clinical settings and to assess the optimized ViTrack™ design to measure and continuously track blood pressure over a wide, clinically-relevant pressure range.

Interventions

DEVICEViTrack device

In the operating room the ViTrack™ device will be applied the wrist. Monitoring will start in the operating room and will continue throughout the surgery. The device can be worn on either wrist. It will be connected to a power unit that will capture blood pressure data and stream the data to a secure laptop

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* scheduled to undergo noncardiac surgery with general or spinal anesthesia * clinical indication for invasive intra-arterial pressure monitoring * palpable pulse

Exclusion criteria

* difference of greater than 10 mmHg in the left versus right arm oscillometric systolic blood pressure * Upper extremity arteriovenous hemodialysis shunt * Upper extremity amputation * Planned surgical position/draping that precludes access to the wrist * Wrist distortion or pain from arthritis * Prior trauma or surgery at the radial artery monitoring site * Unable to provide informed consent * Clinical contraindication as determined by the clinical team or study investigators

Design outcomes

Primary

MeasureTime frameDescription
Comparison of Diastolic Blood PressureFrom start of surgery up to 24 hours after surgery255 time points compared across continuous blood pressure (mmHg)
Comparison of Systolic Blood PressureFrom start of surgery up to 24 hours after surgery255 time points compared across continuous blood pressure (mmHg)

Secondary

MeasureTime frame
Number of participants who show signs of Skin IrritationFrom start of surgery up to 72 hours after surgery

Countries

United States

Contacts

CONTACTMehmet Turan, MD
Mehmet.A.Turan@uth.tmc.edu(713) 500-6251
CONTACTMohammad Khudirat
Mohammad.Khudirat@uth.tmc.edu(713) 500-5558
PRINCIPAL_INVESTIGATORMehmet Turan, MD

The University of Texas Health Science Center, Houston

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026